[Study on orally active cephalosporin pro-drug. Synthesis, oral absorption and antibacterial activity of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 7-[D-O-(aminoacyl)mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol -2-yl)-thio]methyl]-3-cephem-4-carboxylates]. 1988

S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
June 2010, Chemical & pharmaceutical bulletin,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
September 1977, Journal of medicinal chemistry,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
June 1979, Journal of medicinal chemistry,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
August 2016, The journal of physical chemistry. B,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
June 1973, Journal of pharmaceutical sciences,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
May 1988, Arzneimittel-Forschung,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
March 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
December 2016, The journal of physical chemistry. B,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
May 2017, The Journal of antibiotics,
S Nishizawa, and A Yoshimi, and H Muro, and M Kasai, and S Hatano, and H Hashizume, and T Yamada, and E Hashimoto, and K Nishimura, and N Kakeya
October 2005, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!